Clinical analysis revealed 2.2-fold higher DNMT1 mRNA in LN patient PBMCs compared to healthy donors (p < 0.001, Figure 6(A)), paralleling NEAT1 upregulation. The gene discussed is NEAT1; the disease is lobular neoplasia.